Filing Details
- Accession Number:
- 0001181431-15-007072
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-05-18 17:22:46
- Reporting Period:
- 2015-05-15
- Filing Date:
- 2015-05-18
- Accepted Time:
- 2015-05-18 17:22:46
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1501756 | Avalanche Biotechnologies Inc. | [AAVL] | Biological Products, (No Disgnostic Substances) (2836) | 205258327 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1614869 | S. Mark Blumenkranz | C/O Avalanche Biotechnologies, Inc. 1035 O'Brien Drive, Suite A Menlo Park CA 94025 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2015-05-15 | 17,975 | $35.36 | 557,514 | No | 4 | S | Direct | |
Common Stock | Disposition | 2015-05-15 | 4,525 | $36.00 | 552,989 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 11,531 | Indirect | See Footnote |
Common Stock | 11,531 | Indirect | See Footnote |
Common Stock | 11,531 | Indirect | See Footnote |
Footnotes
- Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.
- This transaction was executed in multiple trades in prices ranging from $34.90 to $35.90, inclusive. The price reported in Column 4 above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- This transaction was executed in multiple trades in prices ranging from $35.91 to $36.24, inclusive. The price reported in Column 4 above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- The shares are held directly by the Carla Helene Blumenkranz Irrevocable Trust.
- The shares are held directly by the Erik Davis Blumenkranz Irrevocable Trust.
- The shares are held directly by the Scott Aubrey Blumenkranz Irrevocable Trust.